Objective: Direct compression method is preferable for tablet manufacture. The direct compression method is followed for many formulations but the relevant study is not reported. The present work aims to study the suitability of the direct compression process to prepare tablets of quinapril hydrochloride (QHCl), a low dose drug with a starting dose of 5 mg, indicated in the treatment of hypertension, congestive heart failure, and other conditions.
INTRODUCTION
Tablet is the most popular dosage form existing today because of its convenience of self-administration, compactness, and ease of manufacturing. Tablets may be manufactured by compression granulation and direct compression methods. There has been a growing impetus to develop direct compression formulations. Fluidity and compressibility are prerequisites for direct compression technology [1] . Quinapril hydrochloride (QHCl) is used in the treatment of hypertension or congestive heart failure [2] . The main drawback of QHCl is its instability [3] [4] [5] [6] . It is highly unstable in the presence of moisture, temperature, and excipients. It gets degraded to diketopiperazine in acidic pH and diacid in alkaline pH; it undergoes oxidative degradation leading to discoloration. QHCl is a low dose drug (5 mg-80 mg). The literature review indicates that tablets of many low dose drugs such as felodipine [7] , diazepam [8] , and nitroglycerin [9] have been prepared by direct compression. Magnesium oxide [10] , magnesium carbonate [11] , and ascorbic acid [12] have been reported as stabilizers for QHCl as pH modifiers. Gastroretentive has been prepared by direct compression for QHCl and has been employed in the preparation of gastroretentive floating tablets [13] . In the present work, the suitability of preparation of QHCl tablets employing stabilizers by direct compression method is studied.
METHODS
QHCl was obtained as a gift sample from Aurobindo Pharma Limited. Crospovidone was procured from NR Chemicals. Lactose monohydrate, hydroxypropylmethylcellulose, magnesium carbonate (Light), magnesium oxide (Light), Aerosil, talc, and other analytical grade reagents were supplied by SD Fine Chemicals Ltd.
Estimation of QHCl by ultraviolet-visible (UV-Vis) spectroscopy
UV-vis spectroscopic method is developed for the estimation of QHCl in distilled water at 220 nm with placebo as blank (n=6) [13, 14] .
Stability of aqueous solution of QHCl
Known concentration of QHCl solution in distilled water was prepared. The absorbance was measured at time points of 0, 30, 60, 90, and 120 min (n=3). The stability of QHCl in aqueous solution was determined for the purpose of the evaluation of dissolution study samples.
Estimation by Fourier-transform infrared spectroscopy (FTIR)
Infrared spectroscopy (IR) spectrum of the sample was generated employing potassium bromide (KBr) disk method for QHCl and drugexcipient mixtures, where necessary methanolic solution of the sample was added to KBr and triturated. The mixture was allowed to dry and then compacted for analysis. Adequate care was taken to avoid moisture contamination.
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Estimation by High Performance Liquid Chromatography (HPLC)
HPLC method was developed for the detection of any instability in the drug during formulation and storage [14] . It is employed for a minimal qualitative purpose in this work. Known concentration of QHCl solution in distilled water (HPLC Grade) was prepared and filtered through 0.45 µm filter. Analytical column (ODS Inertsil, 250 mm × 4.6 mm, 5 µ particle size) was used as a stationary phase. A UV-vis detector was set to 214 nm. The mobile phase was composed of acetonitrile phosphate buffer pH 2 (50:50 v/v). 10 µl of sample volume was injected into the column with isocratic elution at a flow rate of 1ml/min for a run time of 6 min. Tablet samples/degraded pure drug samples were first extracted into methanol and further dilutions were made with distilled water (HPLC grade) and analyzed as mentioned above.
Preformulation studies
Determination of melting point, moisture content analysis by moisture balance, particle size and shape analysis by optical microscopy, determination of flow property by angle of repose, and bulk and tapped densities were carried out for QHCl and selected excipients.
Drug excipient compatibility study
Drug excipient compatibility study [15] was performed by taking physical mixtures of drug and excipient (D+E) the ratio of 1:1 (n=3) in glass vials. Pure drug and pure excipient were employed as control at all conditions of the study. All the samples were stored for a period of 4 weeks, respectively, at 40°C and 75% RH, 25°C and 60% RH employing a humidity chamber (Newtronic 204 ETS) and at 60°C in an oven (Biotech). Samples were taken at regular intervals of 1, 2, 3, and 4 weeks for evaluation by physical observation and FTIR. Various fillers, binders [16] , disintegrants, stabilizers, and lubricants were studied for compatibility with drug for direct compression method.
Formulation of QHCl tablets
After evaluating D+E compatibility and excipients properties, QHCl tablets were formulated ( Table 1) .
Preparation of tablets
After collecting the raw materials, blending was carried out by employing trituration and tumbling methods independently. Trituration was carried out in mortar and pestle. Tumbling was carried out using polybags. Powders were blended for 10 min and 15 min, respectively, in each trial by trituration/tumbling. Talc was then added and blended for another 3 min.
Blend uniformity determination
The powder blend was taken on a flat surface and it was leveled to a known thickness. Sample of weight equivalent to three tablets was collected from five locations -the four corners and center from medial height and estimated for drug content. Standard deviation and percentage coefficient of variation (% CV) are calculated.
Pre-compression parameters of blend
The blend was evaluated for precompression parameters such as angle of repose, bulk density, and tapped density.
Compression of QHCl tablets
Tablets were prepared by direct compression using 6 mm circular, flat-faced punches on the rotary tablet compression machine (Model Minipress-1, Gujarat).
Evaluation of tablets
The tablets were evaluated for hardness, thickness, friability, disintegration time, weight variation, and for content uniformity [17] .
In vitro dissolution study
The in vitro dissolution of QHCl tablets was studied using USP Dissolution Apparatus Type II (Paddle Type) Electrolab model no. Fourteen liter in 900 ml of distilled water (media) maintained at 37°C±0.5°C and 100 rpm. The collected samples were filtered and analyzed by UV-vis spectrophotometer after suitable dilutions. A correction factor for the drug lost during sampling was incorporated while calculating the cumulative percentage dissolved.
Stability study
Selected tablets were subjected to preliminary stability studies at 40°C±2°C, 75±5% RH for period of 1 month. Tablets were stored in glass vials in a humidity chamber (Newtronic 204 ETS). Three tablets were analyzed for appearance and drug content. Selected samples were analyzed by HPLC.
RESULTS AND DISCUSSION
UV-Vis Spectrophotometric method
Calibration curve was constructed ( Fig. 1 ). The method was validated for linearity (r 2 = 0.99), accuracy and precision (% CV <5%). The method obeyed Beer's law in the concentration range of 2-15 µg/ml.
Stability of aqueous solution of QHCl
No significant change in absorbance was observed when measured at 220 nm ( Table 2 ). The aqueous solution of the drug was thus determined to be stable during 2 h period and for measurement of dissolution study samples.
Estimation by FTIR
FTIR spectrum could be generated by KBr disk method. All the peaks corresponding to the pure drug were retained in the FTIR spectrum ( . 7) . From all the spectra, it could be seen that characteristic 
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peaks of QHCl were retained. Hence, these excipients were employed in the preparation of QHCl tablets. Literature shows studies carried out for the compatibility of QHCl with HPMC and lactose [3, 4] .
Preformulation study of drug and excipients
The pure drug and excipients were evaluated for various physical properties ( Table 4 ). The melting point of the drug was found to be 119°C in accordance with reported data. The moisture content of pure drug was found to be very low at 0.1%. Angular/tabular particle shape ( Fig. 8 in the formulation. The moisture content of all the excipients which were used in the formulation was very low. The particle size lactose and HPMC used in higher percentage in formulation were close to that of QHCl. All other excipients were in the lower size range. The influence of particle shape and size is clearly reflected in the flow characteristics. Lactose with angular shape showed the poorest flow. HPMC had fibers and spherical particles and showed passable flow. Although particle size is small and shape is spherical, it can be seen that MgCO 3 had poor flow and this may be due to static electricity which leads to adhesiveness of particles [18] . Large variation in micromeritic properties leads to segregation during the direct compression process. However, above study indicates suitability of the drug and excipient combination for the same.
Pre-compression parameters of blend
The formulation of tablets is based on Table 1 . The precompression parameters of the blend ( Table 5 ) showed that the angle of repose 
Blend uniformity
Tumbling and trituration method was compared for blending. From Table 6 , % CV values for QHCl content in the samples indicated variation. For Q1 formulation, the % CV values were higher for the trituration method compared to tumbling method. This may be because during trituration, the entire powder blend will not be subject to displacement from the previous position and there may be dead zones. With tumbling method, geometric dilution was followed to blend drug and diluents. QHCl and lactose have moderate similarity in particle size shape and density (15.75 μm and 17.25 μm; angular and tabular; 0.36g/ml and 0.47 g/ml), respectively ( Table 4 ). The other excipients which were added subsequently get interspersed between the blend due to the smaller particle size and a convenient spherical shape. The smaller particles may also adsorb on to the larger ones. Differences in particle size are the most common cause of segregation in pharmaceutical powders. However, when component of a powder 
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mix has a very small particle size (<5 µm) and other is relatively large in such circumstances, the fine powder may coat the surface of the larger particles. The adhesive forces will prevent segregation. This is known as ordered mixing, using this technique, it is possible to produce greater homogeneity than by random mixing [18] . Segregation of various components based on their density difference may be avoided because of this adsorption. The blend uniformity was better achieved by tumbling method than trituration (Table 6a -c). Although the t-test showed no significant difference between the two methods, tumbling has been chosen over the trituration method based on % CV values. With relevance to the time of blending, between 10 min and 15 min tumbling, the mean of the % CV values indicates a lesser standard deviation (1.04) at 15 min of blending. Similar behavior is observed with Q2 and Q3.
Preparation and evaluation of QHCl tablets
The powder blends showed adequate flow property and content uniformity, QHCl tablets were prepared by direct compression could successfully be prepared by direct compression technique. The tablets were evaluated and data are given in Table 7 . Hardness was found to be 2.5-3 kg/cm 2 for Q1, Q2, but Q3 has a low hardness of 1.5 kg/cm, 
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Dissolution study of QHCl tablets A dissolution study was carried out for Q1 and Q2 ( Fig. 9 ), giving dissolution of 99.2% and 98.8 %, respectively, within 30 min.
Dissolution data is treated by the kinetics of zero-order, first-order, and Hixson-Crowell models ( Figs. 10 and 11 ). From the "r 2 " values ( Table 8) , dissolution is found to follow first-order kinetics and Hixson-Crowell model. 
Stability studies Initial stability study was conducted for one month at 40°C±2°C/75%±5% RH on Q1 and Q2. There was no discoloration observed in the tablets Margret and Madhavi of Q1. The same was evident from chromatogram ( Fig. 12 ) that there are no secondary peaks. The assay was 90% for Q1. Q2 showed colored spots appeared on tablets after 4 weeks and the chromatogram ( Fig. 13 ) indicated peaks at different retention times indicating some degradation. In Q2 as MgCO 3 is employed, the effectiveness in stabilizing the drug is lesser when compared to MgO because MgCO 3 has only 40% of MgO [10] . Tablet hardness and disintegration did not show variation after 1 month.
CONCLUSION
QHCl which is a low dose antihypertensive agent has stability and excipients compatibility issues. As evident from the stability information, the tablets need to be stored in cool dry conditions. A direct compression technique has been employed to prepare tablets. The formulation for direct compression could be prepared by employing stabilizers for the drug. Tumbling and trituration methods have been employed for blending. Blend uniformity, thereby content uniformity for the low dose drug could be attained. QHCl tablets could successfully be prepared by the direct compression method.
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